title: Resistance profiles in surgical-site infection.
abstract: Surgical-site infections (SSIs) remain a common complication, affecting some 5% of patients undergoing surgical procedures and can sometimes present a major challenge after surgery with life-threatening septic illness. The appearance of organisms that are often resistant to common antibiotic treatment is of great concern. Staphylococcus aureus is the organism most commonly recovered from infected surgical wounds, and usually contaminates wounds from the patients own skin. SSIs occur despite appropriate skin disinfection, sterilization of instruments, use of gown and gloves, appropriate sterile technique and prophylactic antimicrobials. In fact, it is difficult to maintain a sterile field over time, and most wounds become contaminated throughout the course of surgery. Methicillin-resistant S. aureus (MRSA) first arose in the hospital setting, but have more recently evolved in the community. Such community-acquired MRSA are genetically different and seem to be even more virulent owing to genes that encode virulence factors, such as staphylococcal cassette chromosome mec type IV and Panton-Valentine leukocidin. The purpose of this review is to summarize characteristics of frequently isolated bacterial strains from SSIs. The focus will be on Gram-positive organisms because of their increasing prevalence in SSIs and their high potential to develop resistance against several antibiotic agents, including vancomycin.
authors.affiliation: Veterans Affairs Medical Center & Department of Surgery, University of Louisville, Louisville, KY 40292, USA. amlenz01@gwise.louisville.edu
authors.forename: Andreas M
authors.initials: AM
authors.lastname: Lenz
authors.forename: Mark
authors.initials: M
authors.lastname: Fairweather
authors.forename: William G
authors.initials: WG
authors.lastname: Cheadle
mesh_terms: D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D006801:Humans; D016106:Methicillin Resistance; D008954:Models, Biological; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D013211:Staphylococcus aureus / Q000145:classification / Q000187:drug effects / Q000254:growth & development*; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology